Chemed Corporation declares a quarterly dividend of 60 cents per share, marking its 218th consecutive dividend payout.
Quiver AI Summary
Chemed Corporation announced that its Board of Directors has declared a quarterly cash dividend of 60 cents per share, which will be payable on December 5, 2025, to shareholders on record as of November 17, 2025. This dividend matches the amount paid in August 2025 and marks the company's 218th consecutive quarterly dividend in its 54-year history as a public company. Based in Cincinnati, Ohio, Chemed operates two major subsidiaries: VITAS Healthcare, the largest provider of hospice care in the U.S., and Roto-Rooter, the leading plumbing and drain cleaning service. The press release includes forward-looking statements pertaining to the company's future performance, warning investors of the risks associated with such projections.
Potential Positives
- Chemed Corporation has announced a quarterly cash dividend of 60-cents per share, demonstrating a consistent return of value to shareholders.
- This marks the 218th consecutive quarterly dividend, highlighting the company's long-standing commitment to maintaining shareholder rewards over its 54 years as a public company.
- The stability in dividend payments, equal to the prior quarter, suggests a strong financial position and ongoing profitability amid market conditions.
- Chemed's operations through VITAS Healthcare and Roto-Rooter illustrate a diverse business model in two essential service sectors, providing stability and growth potential.
Potential Negatives
- The company has maintained a static dividend payment of 60-cents per share, indicating a lack of growth or increase in shareholder returns despite the potential for improved financial performance.
- The mention of inherent risks associated with forward-looking statements may signal to investors that there are uncertainties regarding the company's future performance.
- The press release does not provide any information on financial performance or strategic plans, which may leave investors wanting more details about the company's direction and stability.
FAQ
What is the dividend declared by Chemed Corporation?
Chemed Corporation declared a quarterly cash dividend of 60 cents per share on its capital stock.
When will the dividend be paid?
The dividend will be payable on December 5, 2025, to shareholders of record as of November 17, 2025.
How many consecutive quarterly dividends has Chemed paid?
Chemed has paid 218 consecutive quarterly dividends over its 54 years as a public company.
What are Chemed Corporation's subsidiaries?
Chemed operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter.
Where is Chemed Corporation headquartered?
Chemed Corporation is headquartered in Cincinnati, Ohio.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CHE Congressional Stock Trading
Members of Congress have traded $CHE stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CHE stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CHE Insider Trading Activity
$CHE insiders have traded $CHE stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $CHE stock by insiders over the last 6 months:
- NICHOLAS MICHAEL WESTFALL (Executive Vice President) sold 10,012 shares for an estimated $4,224,162
- KEVIN J MCNAMARA (president and CEO) has made 0 purchases and 2 sales selling 5,000 shares for an estimated $2,240,940.
- SPENCER S LEE (executive vice president) sold 1,500 shares for an estimated $866,985
- GEORGE J III WALSH purchased 200 shares for an estimated $83,420
- PATRICK P GRACE sold 150 shares for an estimated $69,508
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CHE Hedge Fund Activity
We have seen 272 institutional investors add shares of $CHE stock to their portfolio, and 280 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 275,423 shares (+122.7%) to their portfolio in Q3 2025, for an estimated $123,317,894
- POINT72 ASSET MANAGEMENT, L.P. removed 128,684 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $62,660,100
- AQR CAPITAL MANAGEMENT LLC added 123,982 shares (+160.9%) to their portfolio in Q2 2025, for an estimated $60,370,555
- ACADIAN ASSET MANAGEMENT LLC added 102,597 shares (+69.3%) to their portfolio in Q2 2025, for an estimated $49,957,557
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 102,464 shares (-23.2%) from their portfolio in Q2 2025, for an estimated $49,892,795
- FMR LLC removed 82,327 shares (-30.4%) from their portfolio in Q2 2025, for an estimated $40,087,486
- AMERIPRISE FINANCIAL INC removed 76,329 shares (-45.2%) from their portfolio in Q2 2025, for an estimated $37,166,879
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CHE Analyst Ratings
Wall Street analysts have issued reports on $CHE in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 09/10/2025
- Jefferies issued a "Buy" rating on 09/02/2025
- Oppenheimer issued a "Outperform" rating on 07/31/2025
- RBC Capital issued a "Outperform" rating on 07/31/2025
To track analyst ratings and price targets for $CHE, check out Quiver Quantitative's $CHE forecast page.
$CHE Price Targets
Multiple analysts have issued price targets for $CHE recently. We have seen 4 analysts offer price targets for $CHE in the last 6 months, with a median target of $584.5.
Here are some recent targets:
- Joanna Gajuk from B of A Securities set a target price of $595.0 on 09/10/2025
- Brian Tanquilut from Jefferies set a target price of $550.0 on 09/02/2025
- Michael Wiederhorn from Oppenheimer set a target price of $580.0 on 07/31/2025
- Ben Hendrix from RBC Capital set a target price of $589.0 on 07/31/2025
Full Release
CINCINNATI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company’s capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025. This is equal to the dividend paid in August 2025. This represents the 218 th consecutive quarterly dividend paid by Chemed in its 54 years as a public company.
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
CONTACT: Michael D. Witzeman
(513) 762-6714
